| Prev Close | 2.93 |
| Day Low/High | 2.85 / 2.97 |
| 52 Wk Low/High | 0.70 / 3.59 |
| Avg Volume | 730.50K |
| Exchange | NASDAQ |
| Shares Outstanding | 78.80M |
| Market Cap | 232.70M |
| EPS | 0.10 |
| P/E Ratio | 13.32 |
| Div & Yield | N.A. (N.A) |
Investors in Neptune Technologies & Bioresources Inc saw new options become available this week, for the February 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 183 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ENZY, NEPT Downgrades: PRTY, TPVG, UAA Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Supports Validity and Enforceability of Neptune's Patent Estate
Seasoned Leader in Development, Manufacturing, Marketing and Sales of Nutraceutical Products
Positive Momentum Underway
You only need to find a few of these stocks in a year to help enhance your portfolio returns.
